SYNOVIAL-MEMBRANE HISTOLOGY AND IMMUNOPATHOLOGY IN RHEUMATOID-ARTHRITIS AND OSTEOARTHRITIS - INVIVO EFFECTS OF ANTIRHEUMATIC DRUGS

被引:164
作者
HARAOUI, B [1 ]
PELLETIER, JP [1 ]
CLOUTIER, JM [1 ]
FAURE, MP [1 ]
MARTELPELLETIER, J [1 ]
机构
[1] UNIV MONTREAL,DEPT MED,MONTREAL H3C 3J7,QUEBEC,CANADA
来源
ARTHRITIS AND RHEUMATISM | 1991年 / 34卷 / 02期
关键词
D O I
10.1002/art.1780340205
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We examined the histologic and immunopathologic features of the synovial membrane of 18 patients with rheumatoid arthritis (RA) and 12 patients with osteoarthritis (OA) who had undergone total knee arthroplasty. Patients were classified into 5 groups according to therapeutic regimen and disease: RA treated with nonsteroidal antiinflammatory drugs (NSAIDs), RA treated with NSAIDs and prednisone, RA treated with NSAIDs and methotrexate (MTX), OA treated with analgesics, and OA treated with NSAIDs. There were no significant between-group differences in the percentages or the distribution pattern of the infiltrating T cell subsets (CD4, CD8), HLA-DR, or interleukin-2 receptor-bearing cells. However, inflammatory indices, which included the thickness of the lining cell layer and the density of the mononuclear cell infiltrate, were significantly higher in the RA patients treated with prednisone and those treated with MTX (P < 0.05). Similarly, fibrosis was markedly reduced in these 2 groups. The RA patients treated with NSAIDs alone and the 2 groups of patients with OA demonstrated similar profiles. These data suggest that prednisone and MTX may inhibit the development of fibrosis without altering the subsets of the inflammatory cell population. This observation raises the possibility that the action of these 2 drugs may be partly mediated by the suppression of inflammatory mediators that are responsible for fibroblast activation.
引用
收藏
页码:153 / 163
页数:11
相关论文
共 44 条
  • [1] THE MECHANISMS OF ACTION OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS
    ABRAMSON, SB
    WEISSMANN, G
    [J]. ARTHRITIS AND RHEUMATISM, 1989, 32 (01): : 1 - 9
  • [2] DEVELOPMENT OF CRITERIA FOR THE CLASSIFICATION AND REPORTING OF OSTEOARTHRITIS - CLASSIFICATION OF OSTEOARTHRITIS OF THE KNEE
    ALTMAN, R
    ASCH, E
    BLOCH, D
    BOLE, G
    BORENSTEIN, D
    BRANDT, K
    CHRISTY, W
    COOKE, TD
    GREENWALD, R
    HOCHBERG, M
    HOWELL, D
    KAPLAN, D
    KOOPMAN, W
    LONGLEY, S
    MANKIN, H
    MCSHANE, DJ
    MEDSGER, T
    MEENAN, R
    MIKKELSEN, W
    MOSKOWITZ, R
    MURPHY, W
    ROTHSCHILD, B
    SEGAL, M
    SOKOLOFF, L
    WOLFE, F
    [J]. ARTHRITIS AND RHEUMATISM, 1986, 29 (08): : 1039 - 1049
  • [3] WEEKLY PULSE METHOTREXATE IN RHEUMATOID-ARTHRITIS - CLINICAL AND IMMUNOLOGICAL EFFECTS IN A RANDOMIZED, DOUBLE-BLIND-STUDY
    ANDERSEN, PA
    WEST, SG
    ODELL, JR
    VIA, CS
    CLAYPOOL, RG
    KOTZIN, BL
    [J]. ANNALS OF INTERNAL MEDICINE, 1985, 103 (04) : 489 - 496
  • [4] THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS
    ARNETT, FC
    EDWORTHY, SM
    BLOCH, DA
    MCSHANE, DJ
    FRIES, JF
    COOPER, NS
    HEALEY, LA
    KAPLAN, SR
    LIANG, MH
    LUTHRA, HS
    MEDSGER, TA
    MITCHELL, DM
    NEUSTADT, DH
    PINALS, RS
    SCHALLER, JG
    SHARP, JT
    WILDER, RL
    HUNDER, GG
    [J]. ARTHRITIS AND RHEUMATISM, 1988, 31 (03): : 315 - 324
  • [5] BETTENS F, 1984, J IMMUNOL, V132, P261
  • [6] BUTLER DM, 1988, J RHEUMATOL, V15, P1463
  • [7] IMMUNOMODULATORY EFFECTS OF TREATMENT WITH NAPROXEN IN PATIENTS WITH RHEUMATIC DISEASE
    CEUPPENS, JL
    ROBAEYS, G
    VERDICKT, W
    VERTESSEN, S
    DECKMYN, H
    DEQUEKER, J
    [J]. ARTHRITIS AND RHEUMATISM, 1986, 29 (03): : 305 - 311
  • [8] COMBE B, 1985, CLIN EXP IMMUNOL, V59, P520
  • [9] PHENOTYPIC ANALYSIS OF SYNOVIAL TISSUE AND PERIPHERAL-BLOOD LYMPHOCYTES ISOLATED FROM PATIENTS WITH RHEUMATOID-ARTHRITIS
    CUSH, JJ
    LIPSKY, PE
    [J]. ARTHRITIS AND RHEUMATISM, 1988, 31 (10): : 1230 - 1238
  • [10] DANIS VA, 1987, J RHEUMATOL, V14, P33